Webinar - New Opportunities for Value Creation: How Biotechs Can Succeed in an Increasingly Competitive Market

The game has changed in biotech. Continued macroeconomic uncertainty has far reaching implications for the biopharma ecosystem. Access to capital remains low across the industry, and a successful deal with large pharma has become less likely for many. Companies who earlier would have been sellers, may now be progressing development through registrational studies—or all the way through to market. Stated another way, biotechs can no longer operate toward the single goal of being acquired by, or of licensing their assets to, large pharma—accordingly, players may need to develop products further than in the past, and therefore strategic pathway optionality needs to be weaved into and maintained throughout product and corporate development. With these new challenges come multifold new opportunities for value creation.

In this webinar, we discuss strategic and operational implications for the biotech C-suite and share perspectives on how companies can succeed in an increasingly competitive environment. We also look to address some pressing questions such as:

• how far to go as a biotech (and in what circumstances);
• value focused clinical development;
• strategic capital allocation; and
• how patients may benefit in the long run from the evolution and increasing sophistication of the biotech ecosystem.

Meet Our Speakers 

関連コンテンツ

詳細に興味がおありですか？Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below: 

Dealmaker’s Intentions Survey 2023

ウェビナー：商品化の成功を目指すバイオテクノロジー組織の準備と調整

先行きが不透明な時代に透明性がバイオテクノロジー企業の差別化要因になり得るのか

バイオ医薬品の上市を成功させるためのパートナーとなるエージェンシー選びの5つのポイント

Register Now